Sun Pharma to acquire Organon in USD 11.75 billion deal
Sun Pharma→Organon
Apr 28, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
WW International acquisition has announced plans to prepay and reduce debt at WW International, a healthcare services other business in New York, for up to $40 million. WW International operates science-backed weight management programs and an integrated weight health ecosystem that combines coaching, technology, and clinical interventions for subscribers and corporate offerings. The company’s healthcare services other platform supports weight-loss outcomes and access to GLP-1 medications when clinically appropriate, aligning with liquidity and deleveraging goals in NY acquisitions. The other acquisition is structured as a term loan cash sweep plus a voluntary discounted prepayment solicitation, with $25 million to $30 million expected June 24, 2026 and up to $10 million solicited April 27–April 30, 2026, as part of healthcare M&A focused on strengthening capital structure.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
Apr 28, 2026
Sun Pharma→Organon
Apr 28, 2026
IMG Pharma→Matsumoto Pharmaceutical
Apr 27, 2026
TPG→Optum UK
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026